SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 359.22+2.0%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: daveG who wrote (768)1/27/1999 12:18:00 AM
From: Netnut7  Read Replies (1) of 1255
 
21 day moving average has just crossed above 50 day moving average which is very positive. Support around 50 cents seems to be holding. Fundamentally if they received 2 years of operating expenses from the latest partnership with Organon (at least 10 mil), this stock has got to improve from here. A double from 50 cents to a buck within the next 30-60 days does seem highly probable. Actually I thought it was good that the CEO said he didnt care if the stock went into the OTC world. Sounds better than a reverse split to me and besides, look at WCTI, a OTC BB trading over 20 bucks! However, I have a feeling the SEC meeting with CORX will result in an extension, considering the revenue generated from the partnership.
The price will go to 1.25 to 1.5 IMHO and this is just a short term outlook for CORX. Long term, if Amkamines show as much promise as some of the research suggests, we could be be the next NEOT
Kevin A.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext